Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis.
- AnnotationThe expression levels of TPD52 and DNAJB1 were elevated in cholangiocarcinoma (CCA) cell lines tissues and bile samples suggesting that these proteins may contribute to tumor pathogenesis. In addition the expression levels of TPD52 and DNAJB1 were found to be closely associated with the clinical parameters and prognosis of patients with CCA.
- CategoriesExpression, Subcellular Location
- SourceGeneRif: 7163